✦ LIBER ✦

High-dose busulfan, melphalan and thiotepa as consolidation for non-inflammatory high-risk breast cancer

✍ Scribed by Gutierrez-Delgado, F; Holmberg, L A; Hooper, H; Appelbaum, F R; Livingston, R B; Maziarz, R T; Weiden, P; Rivkin, S; Montgomery, P; Kawahara, K

Book ID: 110012634
Publisher: Nature Publishing Group
Year: 2000
Tongue: English
Weight: 88 KB
Volume: 26
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1702461

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose busulfan, melphalan, thiotepa

High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer

✍ Bensinger, W I; Schiffman, K S; Holmberg, L; Appelbaum, F R; Maziarz, R; Montgom 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 152 KB

The use of high-dose cyclophosphamide, c

The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapy

✍ Yee Chung Cheng; Gabriela Rondón; Ying Yang; Terry L. Smith; James L. Gajewski; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 274 KB

High-dose thiotepa, etoposide and carbop

High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma

✍ Franca Falzetti,Mauro Di Ianni,Stelvio Ballanti… 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 235 KB

P92 Low morbidity and no mortality of hi

P92 Low morbidity and no mortality of high-dose cyclophosphamide, thiotepa and mitoxantrone plus autologous peripheral blood stem cell support for high-risk breast cancer patients

✍ N. Kröger; W.H. Krüger; F. Gieseking; F. Jaenicke; W. Schultze; H. Fuss; V. Möbu 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Long-Term Survival after High-Dose Chemo

Long-Term Survival after High-Dose Chemotherapy Followed by Peripheral Stem Cell Rescue for High-Risk, Locally Advanced/Inflammatory, and Metastatic Breast Cancer

✍ VanderWalde, A.; Ye, W.; Frankel, P.; Asuncion, D.; Leong, L.; Luu, T.; Morgan, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 214 KB

Phase III study to evaluate the use of h

Phase III study to evaluate the use of high-dose chemotherapy as consolidation of treatment for high-risk postoperative breast cancer: Japan Clinical Oncology Group study, JCOG 9208

✍ Yutaka Tokuda; Tomoo Tajima; Masaru Narabayashi; Kunihiko Takeyama; Toru Watanab 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB